clinical trial · NCT04982393
BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1)
Primary Hyperoxaluria Type 1
brief summary
The purpose of this study is to describe the natural history and progression of patients diagnosed with PH1, and to characterize the long-term real-world safety and effectiveness of lumasiran.
started
Dec 13, 2021
primary completion
Sep 1, 2028
completion
Sep 1, 2028
last updated
Apr 24, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol